šŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark Ā· Delayed Price Ā· Currency is DKK
211.40
-1.30 (-0.61%)
Nov 20, 2026, 11:00 AM CET

Zealand Pharma Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Zealand Pharma stock has a consensus rating of "Buy" and an average price target of krĀ 383.58. The average 1-year stock price forecast is 81.45% higher than the current stock price, while the lowest is krĀ 280.00 (+32.45%) and the highest is krĀ 550.00 (+160.17%).

Price Target: krĀ 383.58 (+81.45%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
PricekrĀ 280.00krĀ 383.58krĀ 370.00krĀ 550.00
Change+32.45%+81.45%+75.02%+160.17%

Analyst Ratings

The average analyst rating for Zealand Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy655555
Buy333211
Hold788899
Sell111111
Strong Sell000000
Total171717161616

Financial Forecast

Revenue This Year
4.55B
from 9.21B
Decreased by -50.67%
Revenue Next Year
4.23B
from 4.55B
Decreased by -6.86%
EPS This Year
37.13
from 90.22
Decreased by -58.85%
EPS Next Year
6.93
from 37.13
Decreased by -81.35%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
108.55M103.99M342.79M62.69M9.21B4.55B
Revenue Growth
-43.47%-4.20%229.65%-81.71%14,598.86%-50.67%
Gross Profit
97.58M103.99M339.59M54.82M9.21B4.55B
Gross Margin
89.89%100.00%99.07%87.44%99.99%99.99%
Operating Income
-782.14M-816.60M-561.24M-1.27B6.92B1.88B
Net Income
-1.02B-1.20B-703.74M-1.08B6.46B1.96B
EPS
----90.2237.13
EPS Growth
------58.85%
Forward PE
115.37115.37151.8138.433.955.69
Free Cash Flow
----6.50B1.15B
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is DKK.

Revenue Forecast

Revenue202620272028
High4.6B
Avg4.5B
Low4.5B

Revenue Growth

Revenue Growth202620272028
High
-50.5%
Avg
-50.7%
Low
-50.9%

EPS Forecast

EPS202620272028
High37.13
Avg37.13
Low37.13

EPS Growth

EPS Growth202620272028
High
-58.8%
Avg
-58.8%
Low
-58.8%